AVR 3.93% $14.41 anteris technologies ltd

Under the Radar, page-50

  1. 117 Posts.
    lightbulb Created with Sketch. 12
    Thanks for the correction, can safely say that the delay implies nothing negative about Cardiocel but is due to the the nature of a very conservative PS agency. Great to see approval for some of our infusion devices. Anticipating a positive re-rate by Patersons soon. GLTAH
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.